Cargando…

Increased expression of PD-1 and PD-L1 in oral lesions progressing to oral squamous cell carcinoma: a pilot study

Oral cancer is a devastating disease and is commonly preceded by a range of oral premalignant disorders. We investigated the expression of PD-1 and PD-L1 in oral epithelial dysplasia (OED) that progressed to oral squamous cell carcinoma (OSCC) compared to non-progressing dysplasia. 49 oral biopsies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dave, Kanan, Ali, Aiman, Magalhaes, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297711/ https://www.ncbi.nlm.nih.gov/pubmed/32546692 http://dx.doi.org/10.1038/s41598-020-66257-6

Ejemplares similares

Comparison of PD-L1 Expression in Oral Squamous Cell Carcinoma and Premalignant Lesions of Oral Cavity
por: Saeed, Saleha, et al.
Publicado: (2022)

Dynamic Up-Regulation of PD-L1 in the Progression of Oral Squamous Cell Carcinoma
por: Steen, Sonja, et al.
Publicado: (2023)

PD-1/PD-L1 expression in anal squamous intraepithelial lesions
por: Bucau, Margot, et al.
Publicado: (2020)

Prognostic significance of PD‐L2 expression in patients with oral squamous cell carcinoma—A comparison to the PD‐L1 expression profile
por: Weber, Manuel, et al.
Publicado: (2019)

Differences in PD-L1 Expression between oral and oropharyngeal squamous cell carcinoma
por: Blatt, Sebastian, et al.
Publicado: (2022)

CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity
por: Straub, Melanie, et al.
Publicado: (2016)

PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma
por: Tojyo, Itaru, et al.
Publicado: (2019)

Expression of PD-L1 is HPV/P16-independent in oral squamous cell carcinoma
por: Kitichotkul, Kit, et al.
Publicado: (2022)

Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma
por: Knochelmann, Hannah M., et al.
Publicado: (2021)

High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma
por: Lin, Yueh-Min, et al.
Publicado: (2015)

Clinicopathologic implications of the miR-197/PD-L1 axis in oral squamous cell carcinoma
por: Ahn, Hyein, et al.
Publicado: (2017)

PD-L1 expression in tumor tissue and peripheral blood of patients with oral squamous cell carcinoma
por: Weber, Manuel, et al.
Publicado: (2017)

PD‐L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside
por: Nocini, Riccardo, et al.
Publicado: (2022)

PD-L1/PD-1 and CTLA-4 Expression in Equine Penile Squamous Cell Carcinomas
por: Porcellato, Ilaria, et al.
Publicado: (2021)

Importance of the PD-1/PD-L1 Axis for Malignant Transformation and Risk Assessment of Oral Leukoplakia
por: Ries, Jutta, et al.
Publicado: (2021)

Arsenic trioxide (ATO) induced degradation of Cyclin D1 sensitized PD-1/PD-L1 checkpoint inhibitor in oral and esophageal squamous cell carcinoma
por: Zhu, Guanxia, et al.
Publicado: (2020)

Anti-PD-1 Therapy is Beneficial for the Survival of Patients with Oral Squamous Cell Carcinoma
por: Feng, Liang, et al.
Publicado: (2022)

In Situ PD-L1 Expression in Oral Squamous Cell Carcinoma Is Induced by Heterogeneous Mechanisms among Patients
por: Kondo, Yutaro, et al.
Publicado: (2022)

Characterization of Oral Squamous Cell Carcinoma Associated Inflammation: A Pilot Study
por: Laliberté, Catherine, et al.
Publicado: (2021)

Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1(high) with CD8/PD-1(high)
por: Ma, Si-Rui, et al.
Publicado: (2023)

Progress of research on PD-1/PD-L1 in leukemia
por: Cao, Huizhen, et al.
Publicado: (2023)

Oral mucositis. Is it present in the immunotherapy of the immune checkpoint pd1/pd-l1 against oral cancer? A systematic review
por: Peña-Cardelles, Juan Francisco, et al.
Publicado: (2021)

Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment
por: Hirai, Mariko, et al.
Publicado: (2016)

IL-12RB1: a novel immune prognostic biomarker for oral squamous cell carcinoma and linked to PD-1/PD-L1 expression in the tumor immune microenvironment
por: Chen, Zheng, et al.
Publicado: (2022)

METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1
por: Ai, Yilong, et al.
Publicado: (2021)

Cisplatin‐induced HSF1‐HSP90 axis enhances the expression of functional PD‐L1 in oral squamous cell carcinoma
por: Sasaya, Takashi, et al.
Publicado: (2022)

Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma
por: Kim, Hae Su, et al.
Publicado: (2016)

PD-L1-Mediated Immunosuppression in Oral Squamous Cell Carcinoma: Relationship With Macrophage Infiltration and Epithelial to Mesenchymal Transition Markers
por: Wu, Tiantian, et al.
Publicado: (2021)

Progress of PD-1/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma
por: Ju, Feng, et al.
Publicado: (2023)

Investigation of the PD-1/PD-L1 Expression in the Lesional Skins of Patients With Psoriasis
por: Emre, Selma, et al.
Publicado: (2023)

Increased PD-L1 and p16 expression are common in oropharyngeal squamous cell carcinoma
por: Shestakova, Anna, et al.
Publicado: (2021)

The B7 family molecules in oral squamous cell carcinoma: a systematic review. Part I: B7-H1 (PD-L1) and B7-DC (PD-L2)
por: Starzyńska, Anna, et al.
Publicado: (2020)

PD-L1 Expression in Squamous-cell Carcinoma and Adenocarcinoma of the Lung
por: Janzic, Urska, et al.
Publicado: (2017)

A d-peptide-based oral nanotherapeutic modulates the PD-1/PD-L1 interaction for tumor immunotherapy
por: Liu, Dan, et al.
Publicado: (2023)

Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
por: Bai, Jie, et al.
Publicado: (2017)

Macrophages in Oral Carcinomas: Relationship with Cancer Stem Cell Markers and PD-L1 Expression
por: Suárez-Sánchez, Faustino J., et al.
Publicado: (2020)

Immunohistochemical Analysis of Foxp3(+), CD4(+), CD8(+) Cell Infiltrates and PD-L1 in Oral Squamous Cell Carcinoma
por: Stasikowska-Kanicka, Olga, et al.
Publicado: (2017)

Increase of cells expressing PD‐1 and PD‐L1 and enhancement of IFN‐γ production via PD‐1/PD‐L1 blockade in bovine mycoplasmosis
por: Goto, Shinya, et al.
Publicado: (2017)

PD‐L1 and PD‐L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma
por: Okadome, Kazuo, et al.
Publicado: (2021)

Regulation of Immunity in Clear Cell Renal Carcinoma: Role of PD-1, PD-L1, and PD-L2
por: Spirina, Liudmila, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gsekc3g2vr0heb3e54tio6pkau